Evolent Health Q2 2024 Adj EPS $0.30 Beats $0.26 Estimate, Sales $647.14M Beat $636.44M Estimate
Author: Benzinga Newsdesk | August 08, 2024 04:48pm
Evolent Health (NYSE:
EVH) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.26 by 15.38 percent. The company reported quarterly sales of $647.14 million which beat the analyst consensus estimate of $636.44 million by 1.68 percent. This is a 37.94 percent increase over sales of $469.14 million the same period last year.
Posted In: EVH